Citation Impact
Citing Papers
A Comparison of Rate Control and Rhythm Control in Patients with Atrial Fibrillation
2002 Standout
Can Patients at Elevated Risk of Stroke Treated With Anticoagulants Be Further Risk Stratified?
2007
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Primary Prevention of Ischemic Stroke
2006
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
Guidelines for the Primary Prevention of Stroke A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists.
2011
Assessment of Myocardial Viability in Patients With Chronic Coronary Artery Disease
1996
Gender-related differences in risk of cardiovascular morbidity and all-cause mortality in patients hospitalized with incident atrial fibrillation without concomitant diseases: A nationwide cohort study of 9519 patients
2014
Clotting state after cardioversion of atrial fibrillation: a haemostasis index could detect the relationship with the arrhythmia duration.
2005
Aortic Arch Atheroma Progression and Recurrent Vascular Events in Patients With Stroke or Transient Ischemic Attack
2007
A systematic review of the use of theory in the design of guideline dissemination and implementation strategies and interpretation of the results of rigorous evaluations
2010
Effect of hypertension on anticoagulated patients with atrial fibrillation
2007
Use of Continuous Quality Improvement to Increase Use of Process Measures in Patients Undergoing Coronary Artery Bypass Graft Surgery
2003
Ximelagatran compared with warfarin for prevention of thromboembolism in patients with nonvalvular atrial fibrillation: rationale, objectives, and design of a pair of clinical studies and baseline patient characteristics (SPORTIF III and V)
2003
Calcification of the Aortic Arch
2000 Standout
Atrial fibrillation complicating the course of degenerative mitral regurgitation
2002
Diagnosis of cardiac thrombosis in patients with atrial fibrillation in the absence of macroscopically visible thrombi
1993
Surgical treatment of permanent atrial fibrillation using microwave energy ablation: a prospective randomized clinical trial☆
2003
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
Hospitalized Patients With Atrial Fibrillation and a High Risk of Stroke Are Not Being Provided With Adequate Anticoagulation
2005
Left Atrial Appendage Occlusion: Lessons Learned From Surgical and Transcatheter Experiences
2011
Early differentiation of cardioembolic from atherothrombotic cerebral infarction: a multivariate analysis
1999
Prevalence of Left Atrial Thrombus and Dense Spontaneous Echo Contrast in Patients With Short-Term Atrial Fibrillation < 48 Hours Undergoing Cardioversion: Value of Transesophageal Echocardiography to Guide Cardioversion
2009
Universal Definition of Myocardial Infarction
2007 Standout
Impact of preoperative and postoperative atrial fibrillation on outcome after mitral valvuloplasty for nonischemic mitral regurgitation
2005
Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: a double-blind randomised study
2000
Transesophageal echocardiography for the evaluation and management of patients with cerebral ischemia
1999
Underuse of Oral Anticoagulants in Atrial Fibrillation: A Systematic Review
2010
A Risk Score for Predicting Stroke or Death in Individuals With New-Onset Atrial Fibrillation in the Community
2003
Low risk of significant echocardiographic valvulopathy in patients treated with anorectic drugs
2001
Mechanisms linking obesity with cardiovascular disease
2006 StandoutNature
New oral anticoagulants for stroke prevention in atrial fibrillation: impact of gender, heart failure, diabetes mellitus and paroxysmal atrial fibrillation
2012
Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach
2009 Standout
Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on Atrial Fibrillation
2008
Randomized controlled trial of education and feedback for implementation of guidelines for acute low back pain
2003
The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management
2008
Is female sex a risk factor for stroke and thromboembolism in patients with atrial fibrillation? A systematic review and meta-analysis
2014
The Use of Contrast-Enhanced Magnetic Resonance Imaging to Identify Reversible Myocardial Dysfunction
2000 Standout
Improving Test Ordering in Primary Care: The Added Value of a Small-Group Quality Improvement Strategy Compared With Classic Feedback Only
2004
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008
Audit and feedback: effects on professional practice and health care outcomes
2006
Effect of Allopurinol Pretreatment on Free Radical Generation after Primary Coronary Angioplasty for Acute Myocardial Infarction
2003
The metabolic syndrome
2010 Standout
Comparison of Risk Stratification Schemes to Predict Thromboembolism in People With Nonvalvular Atrial Fibrillation
2008
Meta-Analysis of Gender Differences in Residual Stroke Risk and Major Bleeding in Patients With Nonvalvular Atrial Fibrillation Treated With Oral Anticoagulants
2013
Transesophageal echocardiography in patients with recent stroke and normal carotid arteries
2001
Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials
2003
Relation Between Mitral Annular Calcium and Complex Aortic Atheroma in Patients With Cerebral Ischemia Referred for Transesophageal Echocardiography
2007
Maintenance of sinus rhythm with metoprolol CR initiated before cardioversion and repeated cardioversion of atrial fibrillation: a randomized double-blind placebo-controlled study
2007
Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation
2007
Stroke Prevention Using the Oral Direct Thrombin Inhibitor Ximelagatran in Patients with Non-Valvular Atrial Fibrillation
2006
Left atrial spontaneous echo contrast in mitral valve disease: An indicator for an increased thromboembolic risk
1988
Spontaneous echo contrast videodensity isflow-related and is dependent on the relative concentrations of fibrinogen and red blood cells
2003
Newly Detected Atrial Fibrillation and Compliance With Antithrombotic Guidelines
2007
Ventricular Dysfunction and the Risk of Stroke after Myocardial Infarction
1997
Paroxysmal atrial fibrillation
2001
Differential Use of Warfarin for Secondary Stroke Prevention in Patients With Various Types of Atrial Fibrillation
2008
Is atrial fibrillation an inflammatory disorder?
2005
Validation of Clinical Classification Schemes for Predicting Stroke
2001 Standout
Echocardiographic Improvement Over Time After Cessation of Use of Fenfluramine and Phentermine
1999
Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates 11Reprints are not available.
1998 Standout
Improving Quality Improvement Using Achievable Benchmarks For Physician Feedback
2001
Impracticability of Informed Consent in the Registry of the Canadian Stroke Network
2004 Standout
Impact of a Multifaceted Intervention on Cholesterol Management in Primary Care Practices
2009
Coral reefs in the Anthropocene
2017 StandoutNature
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
2009 Standout
Focused 2012 Update of the Canadian Cardiovascular Society Atrial Fibrillation Guidelines: Recommendations for Stroke Prevention and Rate/Rhythm Control
2012
Efficacy and safety of direct oral anticoagulants in patients undergoing cardioversion for atrial fibrillation: A systematic review and meta-analysis of the literature
2015
Effects of sibutramine on ventricular dimensions and heart valves in obese patients during weight reduction
2002
Assessment of female sex as a risk factor in atrial fibrillation in Sweden: nationwide retrospective cohort study
2012
Guidelines for the Primary Prevention of Stroke
2010
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
2011 Standout
Plasma von Willebrand factor, soluble thrombomodulin, and fibrin D-dimer concentrations in acute onset non-rheumatic atrial fibrillation
2004
Left ventricular thrombus formation after first anterior wall acute myocardial infarction
1988
Frequency of Left Ventricular Thrombus in Patients With Anterior Wall Acute Myocardial Infarction Treated With Percutaneous Coronary Intervention and Dual Antiplatelet Therapy
2010
Association of Left Atrial Fibrosis Detected by Delayed-Enhancement Magnetic Resonance Imaging and the Risk of Stroke in Patients With Atrial Fibrillation
2011
Fractional Flow Reserve versus Angiography for Guiding Percutaneous Coronary Intervention
2009 Standout
Net Clinical Benefit of Antithrombotic Therapy in Patients With Atrial Fibrillation and Chronic Kidney Disease
2014
Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or Placebo
1991 Standout
Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation For The Cure Of Atrial Fibrillation Study)†
2005
Absence of Cardiac Valve Dysfunction in Obese Patients Treated with Sibutramine
1999
Effectiveness of Amiodarone for Conversion of Atrial Fibrillation to Sinus Rhythm
2003
Natural history of left ventricular thrombi: Their appearance and resolution in the posthospitalization period of acute myocardial infarction
1990
Echocardiographic Examination of Women Previously Treated With Fenfluramine
2001
Haemostatic Activity in Patients with Atrial Fibrillation Treated with Low-Molecular-Weight Heparin Before and After Electrical Cardioversion
2004
Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation
2010
Left Atrial Appendage Flow Velocity as a Quantitative Surrogate Parameter for Thromboembolic Risk: Determinants and Relationship to Spontaneous Echocontrast and Thrombus Formation–A Transesophageal Echocardiographic Study in 500 Patients with Cerebral Ischemia
2005
Management of Patients With Atrial Fibrillation
1996
Female sex as a risk factor for stroke in atrial fibrillation: a nationwide cohort study
2012
Embolic potential, prevention and management of mural thrombus complicating anterior myocardial infarction: A meta-analysis
1993
Improving discussion of surgical treatment options for patients with breast cancer: local medical opinion leaders versus audit and performance feedback
2000
Prediction of left atrial appendage thrombi in non-valvular atrial fibrillation
2007
Appetite suppressants and valvular heart disease in a population-based sample: the HyperGEN study
2002
Reversal of Phen-Fen associated valvular regurgitation documented by serial echocardiography
2002
ANTICOGULATE OR NOT TO ANTICOGULATE PATIENTS WITH CARDIOMYOPATHY
2001
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
2009 Standout
The Incidence of Stroke after Myocardial Infarction: A Meta-Analysis
2006
Impact of thrombolytic therapy on left ventricular mural thrombi in acute myocardial infarction
1988
Multifaceted intervention to promote β-blocker use in heart failure
2006
Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation
1996 Standout
Low prevalence of valvular heart disease in 226 phentermine-fenfluramine protocol subjects prospectively followed for up to 30 months
1999
Gender-Related Differences in Presentation, Treatment, and Outcome of Patients With Atrial Fibrillation in Europe
2007
Ambulatory sudden cardiac death: Mechanisms of production of fatal arrhythmia on the basis of data from 157 cases
1989 Standout
Improvement in the Diagnosis of Abscesses Associated with Endocarditis by Transesophageal Echocardiography
1991 Standout
Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial
2004
Warfarin, Aspirin, or Both after Myocardial Infarction
2002
Antithrombotic Therapy in Atrial Fibrillation
2004
A Comparison of Rate Control and Rhythm Control in Patients with Recurrent Persistent Atrial Fibrillation
2002 Standout
Valvular Abnormalities and Cardiovascular Status Following Exposure to Dexfenfluramine or Phentermine/Fenfluramine
2000
D-dimer determination as a screening tool to exclude atrial thrombi in atrial fibrillation
2003
Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: Final results of a prospective 4.5-year study
1995
Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation
2006
Development, Prevention, and Potential Reversal of Left Ventricular Hypertrophy in Chronic Kidney Disease
2004
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement
2015 Standout
Combined Aspirin–Oral Anticoagulant Therapy Compared With Oral Anticoagulant Therapy Alone Among Patients at Risk for Cardiovascular Disease
2007
Anemia treatment in the pre-ESRD period and associated mortality in elderly patients
2002
Analysis of the left atrial appendage by magnetic resonance angiography in patients with atrial fibrillation
2006
Myocardial Reperfusion Injury
2007 Standout
Assessment of three schemes for stratifying stroke risk in patients with nonvalvular atrial fibrillation
2000
Echocardiographic “smoke” is produced by an interaction of erythrocytes and plasma proteins modulated by shear forces
1992
Effect of fenfluramine-derivative diet pills on cardiac valves: A meta-analysis of observational studies
2002
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
Long-term Pharmacotherapy of Obesity 2000
2001
Hematologic correlates of left atrial spontaneous echo contrast and thromboembolism in nonvalvular atrial fibrillation
1993
Primary and Secondary Prevention of Cardiovascular Disease
2012
Third Universal Definition of Myocardial Infarction
2012 Standout
Reduced incidence of left ventricular thrombi with intravenous streptokinase in acute anterior myocardial infarction: prospective evaluation by cross-sectional echocardiography
1988
Correction of Anemia with Epoetin Alfa in Chronic Kidney Disease
2006 Standout
Cardiac arrest and resuscitation: A tale of 29 cities
1990
Mitral Annular Calcification and the Risk of Stroke in an Elderly Cohort
1992
Warfarin after anterior myocardial infarction in current era of dual antiplatelet therapy: a randomized feasibility trial
2010
A study of platelet activation in paroxysmal, persistent and permanent atrial fibrillation
2002
The Stroke Practice Improvement Network: A Quasiexperimental Trial of a Multifaceted Intervention to Improve Quality
2010
Infective perivalvular abscess of the aortic ring: Echocardiographic features and clinical course
1990
Mitral regurgitation reduces the risk of stroke in patients with nonrheumatic atrial fibrillation
1998
Atherosclerosis of the aorta: Risk factor, risk marker, or innocent bystander?
2004
Practice‐Level Effects of Interventions to Improve Asthma Care in Primary Care Settings: The Pediatric Asthma Care Patient Outcomes Research Team
2005
Effect of Early Correction of Anemia on the Progression of CKD
2006
Neurohumoral Features of Myocardial Stunning Due to Sudden Emotional Stress
2005 Standout
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Safety of Expedited Anticoagulation in Patients Undergoing Transesophageal Echocardiographic-guided Cardioversion
2006
Transient Atrial Fibrillation Complicating Acute Inferior Myocardial Infarction
2007
Incidence of Stroke in Paroxysmal Versus Sustained Atrial Fibrillation in Patients Taking Oral Anticoagulation or Combined Antiplatelet Therapy
2007
Reversible Myocardial Contraction Abnormalities in Patients With an Acute Noncardiac Illness
1998
Atrial Fibrillation and the Hypercoagulable State: From Basic Science to Clinical Practice
2003
Prothrombotic Activity Is Increased in Patients With Nonvalvular Atrial Fibrillation and Risk Factors for Embolism
2004
Atrial fibrillation and stroke prevention
2007
Rivaroxaban vs. vitamin K antagonists for cardioversion in atrial fibrillation
2014
Antithrombotic Therapy in Atrial Fibrillation
2001
Clinical classification schemes for predicting hemorrhage: Results from the National Registry of Atrial Fibrillation (NRAF)
2006
Atrial Fibrillation
2001
Antithrombotic Therapy for Atrial Fibrillation
2012
Spontaneous Initiation of Atrial Fibrillation by Ectopic Beats Originating in the Pulmonary Veins
1998 Standout
Out-of-hospital cardiac arrest: A six-year experience in a suburban-rural system
1988
Effects of congestive heart failure on plasma von Willebrand factor and soluble P-selectin concentrations in patients with non-valvar atrial fibrillation
2005
Treatment of Comatose Survivors of Out-of-Hospital Cardiac Arrest with Induced Hypothermia
2002 Standout
Incidence of early left ventricular thrombus after acute anterior wall myocardial infarction in the primary coronary intervention era
2009
Circulating levels of collagen type I degradation marker depend on the type of atrial fibrillation
2007
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited
2009 Standout
Incidence of Thromboembolic Complications Within 30 Days of Electrical Cardioversion Performed Within 48 Hours of Atrial Fibrillation Onset
2016
Survival rates from out-of-hospital cardiac arrest: Recommendations for uniform definitions and data to report
1990
Antithrombotic Therapy in Atrial Fibrillation
2008
Serial Echocardiographic and Clinical Evaluation of Valvular Regurgitation Before, During, and After Treatment with Fenfluramine or Dexfenfluramine and Mazindol or Phentermine
1999
Diagnosis and treatment of diseases of the aorta
1997
Dose and duration of fenfluramine-phentermine therapy impacts the risk of significant valvular heart disease
2000
Efficacy and safety of warfarin in dialysis patients with atrial fibrillation: a systematic review and meta-analysis
2016
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2011
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2011
Improving survival from sudden cardiac arrest: the "chain of survival" concept. A statement for health professionals from the Advanced Cardiac Life Support Subcommittee and the Emergency Cardiac Care Committee, American Heart Association.
1991 Standout
Cardiac causes of stroke
2000
The Progression of Fenfluramine-Associated Valvular Heart Disease Assessed by Echocardiography
2001
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Fenfluramine and Phentermine and Cardiovascular Findings
2000
Audit and feedback: effects on professional practice and healthcare outcomes
2012 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss
2005 Standout
Primary Prevention of Ischemic Stroke
2001
A Comparison of Antiarrhythmic-Drug Therapy with Implantable Defibrillators in Patients Resuscitated from Near-Fatal Ventricular Arrhythmias
1997 Standout
Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2012 Clinical Practice Guideline
2013 Standout
Evidence for Possible Involvement of 5-HT2BReceptors in the Cardiac Valvulopathy Associated With Fenfluramine and Other Serotonergic Medications
2000
Mitral Annular Calcification Predicts Cardiovascular Morbidity and Mortality
2003
Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks
2005
Predictors of Systemic Embolism in Patients with Mitral Stenosis: A Prospective Study
1998
Effects of full-dose heparin anticoagulation on the development of left ventricular thrombosis in acute transmural myocardial infarction
1986
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2019 Standout
Antithrombotic Therapy To Prevent Stroke in Patients with Atrial Fibrillation
1999
Cerebral ischemic attacks as a complication of aortic and mitral valve prolapse.
1985
Selecting Patients With Atrial Fibrillation for Anticoagulation
2004
UNIVERSAL DEFINITION OF MYOCARDIAL INFARCTION
2008
Prevalence of Atrial Fibrillation and Antithrombotic Prophylaxis in Emergency Department Patients
2002
Relationship of interleukin-6 and C-Reactive protein to the prothrombotic state in chronic atrial fibrillation
2004
Apixaban compared to heparin/vitamin K antagonist in patients with atrial fibrillation scheduled for cardioversion: the EMANATE trial
2018
Low-Dose Aspirin for Prevention of Stroke in Low-Risk Patients With Atrial Fibrillation
2005
Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial
2003
Classification by type of ventricular arrhythmia predicts frequency of adverse cardiac events from flecainide
1986
Gender Differences in the Risk of Ischemic Stroke and Peripheral Embolism in Atrial Fibrillation
2005
Guidelines for the Primary Prevention of Stroke
2014 Standout
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
2019 Standout
Brugada Syndrome: Report of the Second Consensus Conference
2005 Standout
Clinical and Imaging Findings in Cryptogenic Stroke Patients With and Without Patent Foramen Ovale
2002
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
2006 Standout
Out-of-hospital cardiac arrest: a review of major studies and a proposed uniform reporting system.
1980
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
2006
Contribution of Atrial Fibrillation to Incidence and Outcome of Ischemic Stroke
2005
Predictors of Major Vascular Events in Patients With a Transient Ischemic Attack or Minor Ischemic Stroke and With Nonrheumatic Atrial Fibrillation
1995
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks
2005
Perindopril-Based Blood Pressure–Lowering Reduces Major Vascular Events in Patients With Atrial Fibrillation and Prior Stroke or Transient Ischemic Attack
2005
Plasma von Willebrand Factor and Soluble P-Selectin as Indices of Endothelial Damage and Platelet Activation in 1321 Patients With Nonvalvular Atrial Fibrillation
2002
Dabigatran Versus Warfarin in Patients With Atrial Fibrillation
2011
Prognostic Value of Plasma von Willebrand Factor and Soluble P-Selectin as Indices of Endothelial Damage and Platelet Activation in 994 Patients With Nonvalvular Atrial Fibrillation
2003
Identification, diagnosis and assessment of atrial fibrillation
2006
Influence of implantable cardioverter-defibrillators on the long-term prognosis of survivors of out-of-hospital cardiac arrest.
1993
Local opinion leaders: effects on professional practice and health care outcomes
2011
Thromboembolic complications in atrial fibrillation.
1990
Left Atrial Dysfunction in Patients With Atrial Fibrillation After Successful Rhythm Control for > 3 Months
2005
Efficacy and safety of sustained-release propafenone (propafenone SR) for patients with atrial fibrillation
2003
Postmenopausal Hormone Therapy and Risk of Stroke
2001
Usefulness of high-dose anticoagulants in preventing left ventricular thrombus in acute myocardial infarction
1985
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks
2007
Primary Prevention of Ischemic Stroke
2001
Left Atrial Appendage Dysfunction in Chronic Nonvalvular Atrial Fibrillation is Significantly Associated With an Elevated Level of Brain Natriuretic Peptide and a Prothrombotic State.
2001
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
Molecular and Cellular Mechanisms of Myocardial Stunning
1999
Implications of Stroke Risk Criteria on the Anticoagulation Decision in Nonvalvular Atrial Fibrillation
2000
Cardiac arrest: comparison of paramedic and conventional ambulance services.
1983
Get with the guidelines for cardiovascular secondary prevention: pilot results.
2004
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation—Executive Summary
2006
A cluster-randomized trial to improve stroke care in hospitals
2010
Methods to Encourage the Use of Antenatal Corticosteroid Therapy for Fetal Maturation
1999
Prophylactic anticoagulation for left ventricular thrombi after acute myocardial infarction: A prospective randomized trial
1987
Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
2002 Standout
Markers of Thrombin and Platelet Activity in Patients With Atrial Fibrillation
1999
Detection of atrial high-rate events by continuous Home Monitoring: clinical significance in the heart failure-cardiac resynchronization therapy population
2011
Effectiveness of Public Report Cards for Improving the Quality of Cardiac Care
2009
Effect of early anticoagulation on the frequency of left ventricular thrombi after anterior wall acute myocardial infarction
1986
Atrial Fibrillation and Thromboembolism: A Decade of Progress in Stroke Prevention
1999
Fourth universal definition of myocardial infarction (2018)
2018 Standout
The Evolution of Social Norms
2015
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2006
Use of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Lesions
2016
Left Ventricular Mural Thrombi Complicating Acute Myocardial Infarction
1984
Treatment of ventricular fibrillation. Emergency medical technician defibrillation and paramedic services
1984
Natural History of Valvular Regurgitation 1 Year after Discontinuation of Dexfenfluramine Therapy
2001
Cerebral Ischemic Events After Diagnosis of Mitral Valve Prolapse
2003
Recent Heavy Drinking of Alcohol and Embolic Stroke
1999
Smoke-like echo in the left atrial cavity in mitral valve disease: Its features and significance
1985
Influencing Care in Acute Myocardial Infarction: A Randomized Trial Comparing 2 Types of Intervention
2000
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
Prevention of stroke in patients with atrial fibrillation: current strategies and future directions
2008
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
2010 Standout
Asymptomatic or “Silent” Atrial Fibrillation
2003
High-Dose Atorvastatin after Stroke or Transient Ischemic Attack
2006 Standout
Treatment of Out-of-Hospital Cardiac Arrests with Rapid Defibrillation by Emergency Medical Technicians
1980
Dobutamine Echocardiography Predicts Improvement of Hypoperfused Dysfunctional Myocardium After Revascularization in Patients With Coronary Artery Disease
1995
The Relationship Between Daily Atrial Tachyarrhythmia Burden From Implantable Device Diagnostics and Stroke Risk
2009
AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update
2002
Atrial Fibrillation and the Prothrombotic State in the Elderly
2003
Long-term Follow-up of Left Ventricular Thrombus after Acute Myocardial Infarction
1984
Effect of early systemic thrombolytic therapy on left ventricular mural thrombus formation in acute anterior myocardial infarction
1984
Chagas Disease
2009
Risks for Stroke, Bleeding, and Death in Patients With Atrial Fibrillation Receiving Dabigatran or Warfarin in Relation to the CHADS2 Score: A Subgroup Analysis of the RE-LY Trial
2011
The Effect of a Quality Improvement Collaborative to Improve Antimicrobial Prophylaxis in Surgical Patients
2008
Works of Richard Asinger being referenced
Guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology
2001
The Role of Clinical Opinion Leaders in Guideline Implementation and Quality Improvement
2000
Body Fluid Spaces and Blood Pressure in Hemodialysis Patients During Amelioration of Anemia With Erythropoietin
1990
Mitral regurgitation associated with reduced thromboembolic events in high-risk patients with nonrheumatic atrial fibrillation
1993
Transesophageal Echocardiographic Correlates of Clinical Risk of Thromboembolism in Nonvalvular Atrial Fibrillation
1998
Effect of Local Medical Opinion Leaders on Quality of Care for Acute Myocardial Infarction
1998
ST-Segment Elevation in Conditions Other Than Acute Myocardial Infarction
2003
Left atrial diameter in nonvalvular atrial fibrillation: An echocardiographic study
1999
Pathophysiologic Correlates of Thromboembolism in Nonvalvular Atrial Fibrillation: II. Dense Spontaneous Echocardiographic Contrast (The Stroke Prevention in Atrial Fibrillation [SPAF-III] Study)
1999
Warfarin in Atrial Fibrillation Patients with Moderate Chronic Kidney Disease
2011
Warfarin safety and efficacy in patients with thoracic aortic plaque and atrial fibrillation
1999
The Prevalence of Cardiac Valvular Insufficiency Assessed by Transthoracic Echocardiography in Obese Patients Treated with Appetite-Suppressant Drugs
1998
Pathophysiologic Correlates of Thromboembolism in Nonvalvular Atrial Fibrillation: I. Reduced Flow Velocity in the Left Atrial Appendage (The Stroke Prevention in Atrial Fibrillation [SPAF-III] Study)
1999
Two-dimensional echocardiographic identification of complicated aortic root endocarditis: Implications for surgery
1987
Renal Function during Erythropoietin Therapy for Anemia in Predialysis Chronic Renal Failure Patients
1990
Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)
2011
Left ventricular thrombus
2001
Increasing precordial QRS voltage correlates with improvement in left ventricular function following anterior myocardial infarction
1988
Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy
2000
Use of Transesophageal Echocardiography to Guide Cardioversion in Patients with Atrial Fibrillation
2001
Effect of superoxide dismutase and catalase on regional dysfunction after exercise-induced ischemia
1992
Incidence of Left-Ventricular Thrombosis after Acute Transmural Myocardial Infarction
1981
Effect of Local Medical Opinion Leaders on Quality of Care for Acute Myocardial Infarction: A Randomized Controlled Trial
1999
Tissue acoustic properties of fresh left ventricular thrombi and visualization by two dimensional echocardiography: Experimental observations
1982
Embolic potential of left ventricular thrombi detected by two-dimensional echocardiography.
1984
Suppression of ventricular ectopic depolarizations by flecainide acetate, a new antiarrhythmic agent.
1982
Cardiogenic brain embolism. The second report of the Cerebral Embolism Task Force.
1989
The Prevalence of Cardiac Valvular Insufficiency Assessed by Transthoracic Echocardiography in Obese Patients Treated with Appetitie-Suppressant Drugs
1999
Regional function and perfusion at the lateral border of ischemic myocardium.
1985
Embolic potential of left ventricular thrombus (LVT) detected by two-dimensional echocardiography (2DE)
1981
Factors Associated With Ischemic Stroke During Aspirin Therapy in Atrial Fibrillation
1999
Observations on detecting left ventricular thrombus with two dimensional echocardiography: emphasis on avoidance of false positive diagnoses
1981
Follow-up of 514 consecutive patients with cardiopulmonary arrest outside the hospital
1979
Demonstration of exercise-induced painless myocardial ischemia in survivors of out-of-hospital ventricular fibrillation
1987
Regional stasis of blood in the dysfunctional left ventricle: echocardiographic detection and differentiation from early thrombosis.
1982
Aortic Plaque in Atrial Fibrillation
1999
Reactive oxygen species may cause myocardial reperfusion injury
1985
Echocardiography in Diagnostic Assessment of Stroke
1981
Characteristics of the amiodarone–warfarin interaction during long-term follow-up
2008